Clinical Trials
Chemoembolisation Using Doxorubicin in Treating Patients with Liver Cancer That Cannot be removed by Surgery
This clinical trial is studying how well chemoembolisation using doxorubicin works in treating patients with liver cancer that cannot be removed by surgery.
http://www.clinicaltrials.gov/ct/show/NCT00293397?order=7
Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolisation using Bead Block™ Embolic Agent
A double arm (non-inferiority) 44 patient study to assess the performance of Bead Block in the treatment of uterine fibroids by embolisation with respect to clinical and imaging outcome with comparison of primary safety endpoints to Embosphere.
http://www.clinicaltrials.gov/ct/show/NCT00361036?order=1
Doxorubicin with or without Chemoembolisation in Treating Patients with Advanced Unresectable Hepatocellular carcinoma (Liver Cancer)
This randomised phase III trial is studying doxorubicin alone to see how well it works compared to doxorubicin and chemoembolisation in treating patients with advanced liver cancer that cannot be removed by surgery.
http://www.clinicaltrials.gov/ct/show/NCT00079027?order=4
Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Embolisation (PRECISION V)
The objective of this study is to assess the safety and efficacy of DC Bead™ delivered by intra-arterial embolisation for the treatment of Hepatocellular Carcinoma.